News Release

EMBARGOED until Tuesday, June 18, 2013
Media Contact:
Elizabeth Clausen, +1 414-276-2145,

New MDS Study Groups bring researchers together to focus on MDS mission-driven initiatives

SYDNEY – Abstracts featuring The Movement Disorder Society (MDS) Study Groups will be highlighted during the 17th International Congress of Parkinson’s Disease and Movement Disorders. These new international collaborations stem from the MDS mission to promote research into causes, prevention and treatment of movement disorders.

“The intent is to bring researchers together within the Society to advance neurological sciences and enhance research,” states MDS President, Prof. Guenther Deuschl. “Our field is constantly expanding, and even more success for our patients can be achieved by bringing relevant researchers together to define the needs in a specific area of research.”

The five study groups presenting abstracts at the International Congress include:
• Multiple System Atrophy (MSA), led by Gregor Wenning, Medical University of Innsbruck, Innsbruck, Austria
• Non-motor Symptoms (NMS) in Parkinson’s disease, led by Ray Chaudhuri,
National Parkinson Foundation Center, Kings College Hospital, London, United Kingdom
• Mild Cognitive Impairment (MCI) in Parkinson’s disease, led by Gert J. Geurtsen, AMC, Amsterdam, The Netherlands
• Progressive Supranuclear Palsy (PSP), led by Günter Höglinger, Technical University of Munich, Munich, Germany
• Peduculo-Pontine Nucleus (PPN) Surgery, led by Elena Moro, Joseph Fourier University, Grenoble, France, and Joachim Krauss, Medical University, MHH, Hannover, Germany

All accepted MDS Study Group abstract posters will be displayed Monday through Thursday through the duration of the International Congress. MDS Study Group presentations will take place Wednesday, June 19 from 12:00-13:30 in Exhibition Hall 5. (See Study Group abstracts).

About the 17th International Congress of Parkinson's Disease and Movement Disorders:
Meeting attendees are gathered to learn the latest research findings and state-of-the-art treatment options in Movement Disorders, including Parkinson's disease. More than 2,000 physicians and medical professionals from 70 countries will be able to view over 1,300 scientific abstracts submitted by clinicians from around the world.

About The Movement Disorder Society:
The Movement Disorder Society, an international society of over 4,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about The Movement Disorder Society, visit